102 related articles for article (PubMed ID: 26070755)
1. Experimental Models on Effects of Psychostimulants.
Kõks S
Int Rev Neurobiol; 2015; 120():107-29. PubMed ID: 26070755
[TBL] [Abstract][Full Text] [Related]
2. Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests.
Zernig G; Ahmed SH; Cardinal RN; Morgan D; Acquas E; Foltin RW; Vezina P; Negus SS; Crespo JA; Stöckl P; Grubinger P; Madlung E; Haring C; Kurz M; Saria A
Pharmacology; 2007; 80(2-3):65-119. PubMed ID: 17570954
[TBL] [Abstract][Full Text] [Related]
3. The role of CART in the reward/reinforcing properties of psychostimulants.
Jaworski JN; Jones DC
Peptides; 2006 Aug; 27(8):1993-2004. PubMed ID: 16766084
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical mechanisms in rat behavioral models of the euphorigenic and antihyperkinetic actions of psychomotor stimulant drugs.
Hill RT
Psychopharmacol Bull; 1975 Jul; 11(3):37-8. PubMed ID: 239434
[No Abstract] [Full Text] [Related]
6. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction.
Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR
Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806
[TBL] [Abstract][Full Text] [Related]
7. Implication of NMDA receptors in behavioural sensitization to psychostimulants: a short review.
Landa L; Machalova A; Sulcova A
Eur J Pharmacol; 2014 May; 730():77-81. PubMed ID: 24607409
[TBL] [Abstract][Full Text] [Related]
8. Functional imaging and neurochemical correlates of stimulant self-administration in primates.
Howell LL; Wilcox KM
Psychopharmacology (Berl); 2002 Oct; 163(3-4):352-61. PubMed ID: 12373436
[TBL] [Abstract][Full Text] [Related]
9. Behavioral responses to psychomotor stimulant drugs: localization in the central nervous system.
Evenden JL; Ryan CN
Pharmacol Ther; 1988; 36(2-3):151-72. PubMed ID: 2894675
[No Abstract] [Full Text] [Related]
10. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?
Pierce RC; Kumaresan V
Neurosci Biobehav Rev; 2006; 30(2):215-38. PubMed ID: 16099045
[TBL] [Abstract][Full Text] [Related]
11. Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems.
Zhang J; Xu M
J Addict Dis; 2001; 20(3):7-18. PubMed ID: 11681595
[TBL] [Abstract][Full Text] [Related]
12. Addiction and dose response: the psychomotor stimulant theory of addiction reveals that hormetic dose responses are dominant.
Calabrese EJ
Crit Rev Toxicol; 2008; 38(7):599-617. PubMed ID: 18709568
[TBL] [Abstract][Full Text] [Related]
13. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
[TBL] [Abstract][Full Text] [Related]
14. Nicotine addiction: insights from recent animal studies.
Mathieu-Kia AM; Kellogg SH; Butelman ER; Kreek MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):102-18. PubMed ID: 12110988
[TBL] [Abstract][Full Text] [Related]
15. The psychogenetically selected Roman rat lines differ in the susceptibility to develop amphetamine sensitization.
Corda MG; Piras G; Lecca D; Fernández-Teruel A; Driscoll P; Giorgi O
Behav Brain Res; 2005 Feb; 157(1):147-56. PubMed ID: 15617781
[TBL] [Abstract][Full Text] [Related]
16. Brain mechanisms of drug-induced reinforcement.
Kornetsky C; Porrino LJ
Res Publ Assoc Res Nerv Ment Dis; 1992; 70():59-77. PubMed ID: 1311122
[TBL] [Abstract][Full Text] [Related]
17. A single social defeat induces short-lasting behavioral sensitization to amphetamine.
de Jong JG; Wasilewski M; van der Vegt BJ; Buwalda B; Koolhaas JM
Physiol Behav; 2005 Jan; 83(5):805-11. PubMed ID: 15639166
[TBL] [Abstract][Full Text] [Related]
18. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
Niwa M; Yan Y; Nabeshima T
Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
[TBL] [Abstract][Full Text] [Related]
19. Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats.
Suzuki T; Fukuoka Y; Mori T; Miyatake M; Narita M
Eur J Pharmacol; 2004 Sep; 498(1-3):157-61. PubMed ID: 15363990
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.
Gruner JA; Mathiasen JR; Flood DG; Gasior M
J Pharmacol Exp Ther; 2011 May; 337(2):380-90. PubMed ID: 21300706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
